Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats.
Shao-Jung HsuHui-Chun HuangChiao-Lin ChuangChing-Chih ChangMing-Chih HouFa-Yauh LeeShou-Dong LeePublished in: Pharmaceutics (2020)
LCZ696 and valsartan reduced mean arterial pressure through peripheral vasodilation. Furthermore, LCZ696 significantly reduced portal pressure in PVL rats via hepatic ET-1 downregulation.